Early-stage gastric and gastroesophageal junction cancer: Is there a survival benefit to neoadjuvant therapy?
Author:
Waller Giacomo C.ORCID,
Patel Dhruv J.ORCID,
Baker Marshall S.
Reference9 articles.
1. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006
2. Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial;Iwasaki;Gastric Cancer,2021
3. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
4. Gastric cancer, version 1.2022, NCCN clinical practice guidelines in oncology;Ajani;J Natl Compr Cancer Netw,2022
5. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial;Ychou;J Clin Oncol,2011
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献